Citation

BibTex format

@inproceedings{Curry:2015:10.1158/1557-3265.OVCASYMP14-AS20,
author = {Curry, E and Cheraghchi-Bashi-Astaneh, A and Chen, M and Cunnea, P and De, Sousa C and Maginn, E and Dai, Y and Liu, E and Wasan, H and Mills, G and Bowtell, D and Gabra, H and Stronach, EA},
doi = {10.1158/1557-3265.OVCASYMP14-AS20},
publisher = {AMER ASSOC CANCER RESEARCH},
title = {DNA-PKcs is amplified in high grade serous ovarian cancer (HGSC), correlates with poor outcome and drives resistance to platinum therapy via the AKT signaling pathway},
url = {http://dx.doi.org/10.1158/1557-3265.OVCASYMP14-AS20},
year = {2015}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Curry,E
AU  - Cheraghchi-Bashi-Astaneh,A
AU  - Chen,M
AU  - Cunnea,P
AU  - De,Sousa C
AU  - Maginn,E
AU  - Dai,Y
AU  - Liu,E
AU  - Wasan,H
AU  - Mills,G
AU  - Bowtell,D
AU  - Gabra,H
AU  - Stronach,EA
DO  - 10.1158/1557-3265.OVCASYMP14-AS20
PB  - AMER ASSOC CANCER RESEARCH
PY  - 2015///
SN  - 1078-0432
TI  - DNA-PKcs is amplified in high grade serous ovarian cancer (HGSC), correlates with poor outcome and drives resistance to platinum therapy via the AKT signaling pathway
UR  - http://dx.doi.org/10.1158/1557-3265.OVCASYMP14-AS20
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000361386100018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER  -
Download

Ovarian cancer action logo

Learn more about the work of